13F filer · CIK 1600004
First Light Asset Management, LLC
Edina, MN · filing since Q4 2013 · last filing Aug 14, 2026
Reported value
$1.6B
+$529.4M vs prior
Positions
31
New / sold out
2 / 6
Added / reduced
17 / 12
Turnover
17.3%
buys $391.4M · sells $239.1M
Top-10 weight
60.7%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | ENLIVEN THERAPEUTICS INC | +1,158,883 | +574.1% | +$58.8M |
| Added | APOGEE THERAPEUTICS INC | +353,605 | +61.3% | +$46.9M |
| Added | SI-BONE INC | +2,774,795 | +51.8% | +$45.3M |
| New | TREVI THERAPEUTICS INC | +2,097,215 | – | +$39.1M |
| Added | NEOGENOMICS INC | +2,549,545 | +26.2% | +$37.2M |
| Added | GENEDX HOLDINGS CORP | +540,996 | +222.7% | +$37.1M |
| Added | TANDEM DIABETES CARE INC | +2,068,838 | +157.4% | +$31.2M |
| Added | GUARDANT HEALTH | +161,287 | +57.5% | +$24.2M |
| New | TACTILE SYSTEMS TECHNOLOGY INC | +462,562 | – | +$13.8M |
| Added | VAXCYTE INC | +203,373 | +143.4% | +$11.8M |
9 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | CENTESSA PHARMACEUTICALS LIMITED | -1,560,991 | -100.0% | $-62.0M |
| Reduced | AXOGEN INC | -1,254,407 | -31.3% | $-57.9M |
| Reduced | PALVELLA THERAPEUTICS INC | -208,857 | -21.3% | $-31.9M |
| Reduced | TWIST BIOSCIENCE CORPORATION | -150,915 | -17.2% | $-15.5M |
| Sold out | WAVE LIFE SCIENCES LTD | -1,843,968 | -100.0% | $-13.4M |
| Sold out | VERA THERAPEUTICS INC | -313,906 | -100.0% | $-12.6M |
| Sold out | MIMEDX GROUP INC | -2,842,892 | -100.0% | $-11.2M |
| Sold out | SPYGLASS PHARMA INC | -375,000 | -100.0% | $-9.7M |
| Sold out | ORGANOGENESIS HOLDINGS INC | -3,498,533 | -100.0% | $-8.3M |
| Reduced | ESTABLISHMENT LABS HOLDINGS | -61,161 | -19.9% | $-5.2M |
8 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | NEOGENOMICS INCCOMMON STOCKS | 12,279,523 | $179.2M | 10.89% |
| 2 | SI-BONE INCCOMMON STOCKS | 8,127,985 | $132.6M | 8.06% |
| 3 | AXOGEN INCCOMMON STOCKS | 2,748,361 | $126.9M | 7.72% |
| 4 | APOGEE THERAPEUTICS INCCOMMON STOCKS | 930,289 | $123.5M | 7.50% |
| 5 | PALVELLA THERAPEUTICS INCCOMMON STOCKS | 771,901 | $118.0M | 7.17% |
| 6 | TWIST BIOSCIENCE CORPORATIONCOMMON STOCKS | 727,933 | $74.9M | 4.55% |
| 7 | ENLIVEN THERAPEUTICS INCCOMMON STOCKS | 1,360,750 | $69.1M | 4.20% |
| 8 | GUARDANT HEALTHCOMMON STOCKS | 441,586 | $66.3M | 4.03% |
| 9 | 908 DEVICES INCCOMMON STOCKS | 6,282,804 | $54.7M | 3.32% |
| 10 | AMYLYX PHARMACEUTICALS INCCOMMON STOCKS | 3,023,256 | $54.3M | 3.30% |
21 more rows. Subscribe for $29/month to see every row, download the data and use the API.